Search

TransMedics Group Inc

Cerrado

SectorSanidad

72.38 7.5

Resumen

Variación precio

24h

Actual

Mínimo

67.37

Máximo

74.55

Métricas clave

By Trading Economics

Ingresos

7.4M

15M

Ventas

16M

190M

P/B

Media del Sector

17.095

51.78

BPA

0.44

Margen de beneficios

7.729

Empleados

898

EBITDA

9.4M

37M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+44.71% upside

Dividendos

By Acuity

Próximas Ganancias

5 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-507M

2.3B

Apertura anterior

64.88

Cierre anterior

72.38

TransMedics Group Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

3 nov 2026, 23:01 UTC

TransMedics Group, Inc. shares are modestly higher in after-market trading, moving with the broader market amid strong U.S. economic indicators and midterm election implications.

2 nov 2026, 23:16 UTC

TransMedics Group, Inc. is trading modestly lower in after-market hours, continuing a broader trend of declines over the past month.

30 oct 2026, 20:08 UTC

TransMedics Group, Inc. shares fell sharply, closing significantly lower amid notable volatility, reaching its lowest point in the afternoon session.

29 oct 2026, 23:16 UTC

TransMedics Group, Inc. shares are trading modestly lower in after-market hours, continuing a decline observed over the last seven sessions amid sector weakness.

28 oct 2026, 23:06 UTC

TransMedics Group, Inc. is trading modestly higher in after-market hours, recovering from an initial low following eight consecutive sessions of lower finishes.

26 oct 2026, 20:02 UTC

Transmedics Group Inc shares fell sharply, continuing a downward trend with four consecutive daily declines, significantly below their 20-day moving average.

23 oct 2026, 19:36 UTC

Transmedics Group Inc shares are modestly lower, marking the fourth consecutive session of losses, and remain significantly below their 20-day moving average.

22 oct 2026, 21:11 UTC

News

TransMedics Group Inc. will report its third-quarter financial results on November 5, 2026, after the market closes, with a conference call scheduled for 4:30 p.m. ET.

21 oct 2026, 20:07 UTC

Transmedics Group Inc shares are declining sharply, reversing early gains and trading below their 20-day moving average amid ongoing weakness since Tuesday's close.

20 oct 2026, 20:01 UTC

News

TransMedics Group Inc is positioned to benefit from the Trump administration's proposed kidney care plan aimed at enhancing competition and innovation in kidney treatment.

16 oct 2026, 20:02 UTC

Transmedics Group Inc shares are declining, reversing a trend of higher daily closes that persisted since Thursday's close.

15 oct 2026, 19:46 UTC

Social Media

Stifel projects Transmedics Group Inc. will report third-quarter revenue between $185 million and $190 million, exceeding the Street's estimate of $178 million.

14 oct 2026, 20:07 UTC

Transmedics Group Inc shares fell sharply, closing significantly lower compared to Tuesday's close and reaching a low around midday.

13 oct 2026, 20:02 UTC

News
Social Media

Canaccord Genuity maintains Buy rating on TransMedics Group Inc while lowering price target to $94.00, reflecting ongoing confidence in the company's prospects.

9 oct 2026, 20:06 UTC

Transmedics Group Inc shares are declining, unable to sustain an early spike, and are currently positioned significantly below their 20-day moving average.

8 oct 2026, 20:07 UTC

Transmedics Group Inc shares declined sharply on Thursday, finishing notably lower and remaining substantially below their 20-day moving average.

7 oct 2026, 19:50 UTC

Social Media
News

TransMedics Group Inc. advanced after Barclays initiated coverage with an Overweight rating and a $120 price target, despite earlier pulling back from a session high.

5 oct 2026, 20:06 UTC

News

Transmedics Group Inc shares rose following Piper Sandler's initiation of coverage with an "Overweight" rating and a $100 price target.

2 oct 2026, 20:07 UTC

Transmedics Group Inc is gaining amid a broader market rally, driven by falling U.S. Treasury yields and improved investor sentiment since Thursday's close.

1 oct 2026, 20:02 UTC

Transmedics Group Inc shares fell sharply, reversing a recent trend of higher daily closes amid a shift in the asset's performance.

30 sept 2026, 19:15 UTC

Transmedics Group Inc shares fell after an early rise, currently trading below the 20-day moving average and near the lower end of its one-month range.

29 sept 2026, 19:45 UTC

Transmedics Group Inc is trading higher, rebounding from an early dip, although it remains below its 20-day moving average and near the lower end of its one-month range.

25 sept 2026, 20:07 UTC

Social Media

Transmedics Group Inc. shares rose following Canada's first Organ Care System heart transplant, expected to boost donor heart availability by 40%.

24 sept 2026, 20:07 UTC

Transmedics Group Inc shares fell sharply, continuing a downward trend from Wednesday and finishing significantly below its 20-day moving average.

23 sept 2026, 20:07 UTC

News

Transmedics Group Inc shares fell amid a broader market decline, despite reaffirming 2026 revenue guidance of $737 million to $757 million.

22 sept 2026, 19:15 UTC

News

Transmedics Group Inc. appointed Fernando Araujo as CFO and reaffirmed 2026 revenue guidance of $737M to $757M, with shares trading higher.

21 sept 2026, 20:06 UTC

Social Media

Transmedics Group Inc is trading higher following validation from a federal agency and a $7.27M contract for liver recovery services from Veterans Integrated Service Network 4.

18 sept 2026, 20:06 UTC

Transmedics Group Inc shares fell, closing below Thursday's level after fluctuating throughout the day, marking three consecutive sessions of lower closes.

17 sept 2026, 20:07 UTC

Transmedics Group Inc shares fell Thursday, declining from Wednesday's close despite a brief earlier rebound, amid overall lower market performance.

16 sept 2026, 20:10 UTC

Transmedics Group Inc shares fell modestly amid a broader market decline, stabilizing near the midpoint of its one-month range.

Comparación entre iguales

Cambio de precio

TransMedics Group Inc previsión

Precio Objetivo

By TipRanks

44.71% repunte

Estimación a 12 Meses

Media 97.444 USD  44.71%

Máximo 122 USD

Mínimo 65 USD

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para TransMedics Group Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

11 ratings

7

Comprar

4

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de TransMedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
help-icon Live chat